The Hypoxic Microenvironment of Breast Cancer Cells Promotes Resistance in Radiation Therapy

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Mar 8

PMID 33680952

Citations 14

Authors

Cordell Gilreath

Marjan Boerma

Zhiqiang Qin

M Keith Hudson

Shanzhi Wang

Affiliations

Soon will be listed here.

Abstract

The American Cancer Society has estimated an expected 279,100 new breast cancer cases, and an expected 42,690 breast cancer deaths in the U.S. for the year 2020. This includes an estimated 276,480 women who are expected to be diagnosed. Radiation therapy, also called ionizing radiation therapy, is one of the most frequently used methods in the treatment of breast cancer. While radiation therapy is used in the treatment of more than 50% of all cancer cases, tumor resistance to ionizing radiation presents a major challenge for effective cancer treatment. Most tumor cells are in a hypoxic microenvironment that promotes resistance to radiation therapy. In addition to radiation resistance, the hypoxic microenvironment also promotes cancer proliferation and metastasis. In this review, we will discuss the hypoxic microenvironment of breast cancer tumors, related signaling pathways, breast cancer stem-like cells, and the resistance to radiation therapy. Recent developments in our understanding of tumor hypoxia and hypoxic pathways may assist us in developing new strategies to increase cancer control in radiation therapy.

Citing Articles

Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment.

Capatina A, Malcolm J, Stenning J, Moore R, Bridge K, Brackenbury W Front Cell Dev Biol. 2024; 12:1421629.

PMID: 39282472 PMC: 11392762. DOI: 10.3389/fcell.2024.1421629.

Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer.

Musleh Ud Din S, Streit S, Huynh B, Hana C, Abraham A, Hussein A Int J Mol Sci. 2024; 25(4).

PMID: 38396737 PMC: 10888675. DOI: 10.3390/ijms25042060.

Synergistic anticancer effect of Pistacia lentiscus essential oils and 5-Fluorouracil co-loaded onto biodegradable nanofibers against melanoma and breast cancer.

Alabrahim O, Azzazy H Discov Nano. 2024; 19(1):27.

PMID: 38353827 PMC: 10866856. DOI: 10.1186/s11671-024-03962-5.

Nanotechnology Applications in Breast Cancer Immunotherapy.

Wang R, Kumar P, Reda M, Wallstrum A, Crumrine N, Ngamcherdtrakul W Small. 2023; 20(41):e2308639.

PMID: 38126905 PMC: 11493329. DOI: 10.1002/smll.202308639.

Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer.

Cotino-Najera S, Herrera L, Dominguez-Gomez G, Diaz-Chavez J Front Pharmacol. 2023; 14:1287505.

PMID: 38026933 PMC: 10667487. DOI: 10.3389/fphar.2023.1287505.

References

Hara T, Iwadate M, Tachibana K, Waguri S, Takenoshita S, Hamada N . Metastasis of breast cancer cells to the bone, lung, and lymph nodes promotes resistance to ionizing radiation. Strahlenther Onkol. 2017; 193(10):848-855. DOI: 10.1007/s00066-017-1165-2. View

Jokilehto T, Rantanen K, Luukkaa M, Heikkinen P, Grenman R, Minn H . Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clin Cancer Res. 2006; 12(4):1080-7. DOI: 10.1158/1078-0432.CCR-05-2022. View

Blancher C, Moore J, Talks K, Houlbrook S, Harris A . Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res. 2001; 60(24):7106-13. View

Croker A, Allan A . Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells. Breast Cancer Res Treat. 2011; 133(1):75-87. DOI: 10.1007/s10549-011-1692-y. View

Dales J, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut M . Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer. 2005; 116(5):734-9. DOI: 10.1002/ijc.20984. View

Jabbari N, Nawaz M, Rezaie J . Ionizing Radiation Increases the Activity of Exosomal Secretory Pathway in MCF-7 Human Breast Cancer Cells: A Possible Way to Communicate Resistance against Radiotherapy. Int J Mol Sci. 2019; 20(15). PMC: 6696324. DOI: 10.3390/ijms20153649. View

Semenza G . Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol. 2011; 76:347-53. DOI: 10.1101/sqb.2011.76.010678. View

Arany Z, Huang L, Eckner R, Bhattacharya S, Jiang C, Goldberg M . An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A. 1996; 93(23):12969-73. PMC: 24030. DOI: 10.1073/pnas.93.23.12969. View

Boelens M, Wu T, Nabet B, Xu B, Qiu Y, Yoon T . Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014; 159(3):499-513. PMC: 4283810. DOI: 10.1016/j.cell.2014.09.051. View

10.

Ma F, Li H, Wang H, Shi X, Fan Y, Ding X . Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC). Cancer Lett. 2014; 353(2):153-9. DOI: 10.1016/j.canlet.2014.06.022. View

11.

Grinan-Lison C, Olivares-Urbano M, Jimenez G, Lopez-Ruiz E, Del Val C, Morata-Tarifa C . miRNAs as radio-response biomarkers for breast cancer stem cells. Mol Oncol. 2020; 14(3):556-570. PMC: 7053246. DOI: 10.1002/1878-0261.12635. View

12.

Nam Y, Chen C, Gregory R, Chou J, Sliz P . Molecular basis for interaction of let-7 microRNAs with Lin28. Cell. 2011; 147(5):1080-91. PMC: 3277843. DOI: 10.1016/j.cell.2011.10.020. View

13.

Brennan D, Jirstrom K, Kronblad A, Millikan R, Landberg G, Duffy M . CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res. 2006; 12(21):6421-31. DOI: 10.1158/1078-0432.CCR-06-0480. View

14.

Jiang B, Agani F, Passaniti A, Semenza G . V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 1997; 57(23):5328-35. View

15.

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

16.

Zheng X, Linke S, Dias J, Zheng X, Gradin K, Wallis T . Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci U S A. 2008; 105(9):3368-73. PMC: 2265116. DOI: 10.1073/pnas.0711591105. View

17.

Qi X, Pajonk F, McCloskey S, Low D, Kupelian P, Steinberg M . Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation. Radiother Oncol. 2017; 124(3):455-461. PMC: 6128144. DOI: 10.1016/j.radonc.2017.08.019. View

18.

Lin H, Hsieh F, Song H, Lin J . Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Br J Cancer. 2005; 93(12):1372-81. PMC: 2361529. DOI: 10.1038/sj.bjc.6602862. View

19.

Phillips T, McBride W, Pajonk F . The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006; 98(24):1777-85. DOI: 10.1093/jnci/djj495. View

20.

Sorensen K, Thomassen M, Tan Q, Bak M, Cold S, Burton M . Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat. 2013; 142(3):529-36. DOI: 10.1007/s10549-013-2776-7. View